89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,488,481 | -15.0% | 161,171 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $2,928,798 | +260.0% | 154,554 | +189.3% | 0.00% | – |
| Q1 2023 | $813,648 | +28691.5% | 53,424 | +23964.9% | 0.00% | – |
| Q4 2022 | $2,826 | +182.6% | 222 | +22.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 182 | +219.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 57 | -59.6% | 0.00% | – |
| Q1 2022 | $1,000 | -97.9% | 141 | -96.1% | 0.00% | – |
| Q4 2021 | $48,000 | +2300.0% | 3,652 | +2869.1% | 0.00% | – |
| Q2 2021 | $2,000 | -96.7% | 123 | -95.1% | 0.00% | – |
| Q1 2021 | $60,000 | -87.6% | 2,532 | -87.2% | 0.00% | – |
| Q4 2020 | $483,000 | +355.7% | 19,826 | +381.8% | 0.00% | – |
| Q3 2020 | $106,000 | +30.9% | 4,115 | +1.6% | 0.00% | – |
| Q2 2020 | $81,000 | +22.7% | 4,052 | +54.3% | 0.00% | – |
| Q1 2020 | $66,000 | +1000.0% | 2,626 | +998.7% | 0.00% | – |
| Q4 2019 | $6,000 | – | 239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |